ATMI, Inc. (Nasdaq:ATMI) today announced that it has further
extended its global biopharma manufacturing footprint with the
opening of a new Chinese manufacturing facility as part of a joint
venture with Austar, a Hong Kong-based comprehensive service
provider to the China pharmaceutical industry.
The joint venture, ATMI Austar LifeSciences Limited, originated
with the goal of producing and marketing high-end, ultra-clean
sterile materials packaging for active pharmaceutical ingredients
(APIs) and sterile pharmaceutical components to meet growing demand
across the biopharmaceutical industry in the Asia-Pacific region.
The new state-of-the-art manufacturing facility in Beijing, which
was brought online today at an official Grand Opening ceremony
attended by customers and Chinese FDA and government officials,
represents a significant step toward that goal.
Under the joint venture agreement, ATMI Austar LifeSciences will
be producing certain ATMI LifeSciences products, including
CleansteamTM products, with local blow-film extrusion and packaging
converting lines using a copy-exact strategy. The new Beijing
facility also offers potential expansion opportunities for ATMI's
IntegrityTM line of bioprocess vessels (BPVs) manufacturing, which
management says could be rolled out directly as the Asian biotech
market continues to emerge.
"This joint venture not only provides ATMI LifeSciences with
access to the API and biopharmaceutical markets in Asia but also
access to Austar's existing ISO Class V GMP-certified,
cleanroom-based infrastructure that we can begin to leverage
immediately," commented Mario Philips, General Manager and Senior
Vice-President of ATMI LifeSciences. "Together, under the
ATMI Austar LifeSciences banner, we are working to create a new
standard for advanced materials packaging for pharmaceutical
manufacturing throughout the region."
The new Beijing facility's capabilities include blow extrusion
of films and ultra clean packaging converting and assembly lines,
for use in ultra-clean sterile packaging applications for steam or
gamma irradiation applications. In addition to film extrusion
and packaging converting lines, the facility also features
warehousing and significant cleanroom extension
opportunities. It will also serve as a back-up facility for
ATMI LifeSciences' Hoegaarden, Belgium plant, providing enhanced
supply chain security and contingency for ATMI customers
globally.
"We believe that the flexibility and value that we offer will
result in the pharmaceutical manufacturers converting to the
film-based, single-use packaging products that ATMI Austar
LifeSciences will be able to provide locally," added Mars Ho, Chief
Executive Officer of Austar. "The pharmaceutical market in Asia is
expanding rapidly as more multinational firms look to extend their
manufacturing capabilities into this vital region. Local supply and
support is an important competitive differentiator."
This addition to ATMI's manufacturing base comes just three
months after the completion of a two-year, multi-million-dollar
expansion project for its Bloomington, Minnesota manufacturing
facility. With that expansion, ATMI established its North American
hub for the production, marketing and development of its
IntegrityTM single-use technologies for biopharmaceutical and other
life science applications.
About Austar
Austar is a comprehensive service provider to the China
pharmaceutical industry. Customers include multinational
pharmaceutical companies and scientific research institutions.
Founded in Hong Kong in 1991, Austar provides engineering design
and project management services, technical support services, and
Good Manufacturing Practices consultancy through its branch offices
and companies in Beijing, Shanghai, Shijiazhuang, Guangzhou, and
Chengdu in China. More information is available at
http://www.austar.com.cn.
About ATMI
ATMI, Inc. provides specialty semiconductor materials,
leading-edge materials development science, and high-purity
materials handling and delivery solutions designed to increase
process efficiencies for the worldwide semiconductor, flat panel,
and life sciences industries. For more information, please visit
http://www.atmi.com.
The ATMI, Inc. logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=5254
About ATMI LifeSciences
ATMI LifeSciences is a leader in single-use mixing, storage, and
bioreactor technology, fluoropolymer-based products, and
custom-engineered, flexible packaging solutions. The business's
fundamental knowledge of polymers, specially selected resins, and
its clean room manufacturing experience combine to help drive
optimum performance in critical disposable process operations. For
more information, please visit www.atmi-lifesciences.com.
© 2010 ATMI, Inc. All rights reserved. ATMI, the ATMI logo,
Cleansteam, and Integrity are trademarks or registered trademarks
of ATMI, Inc., in the United States, other countries or both.
Statements contained herein that relate to ATMI's future
performance, including, without limitation, statements with respect
to ATMI's anticipated results of operations or level of business
for 2010 or any other future period, are forward-looking statements
within the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995. Such statements are based on current
expectations only and are subject to certain risks, uncertainties,
and assumptions, including, but not limited to, changes in
semiconductor industry growth (including, without limitation, wafer
starts) or ATMI's markets; competition, problems, or delays
developing, commercializing and delivering new products; problems
or delays in integrating acquired operations and businesses;
uncertainty in the credit and financial markets; and other factors
described in ATMI's Form 10-K for the year ended December 31, 2009,
and other subsequent filings with the Securities and Exchange
Commission. Such risks and uncertainties may cause actual results
to differ materially from those expressed in our forward-looking
statements. ATMI undertakes no obligation to update any
forward-looking statements.
CONTACT: ATMI, Inc.
Dean Hamilton, Director, ATMI Investor Relations &
Corporate Communications
203.207.9349
203.794.1100 x4202
dhamilton@atmi.com
Impress Public Relations
Media Enquiries
Richard Kerns
+ 44 (0)161-728-5880
richard@impress-pr.com
Erin Hatzi
+ (1) 503-928-7870
erin@impress-pr.com
Atmi Inc. (MM) (NASDAQ:ATMI)
Historical Stock Chart
From Jun 2024 to Jul 2024
Atmi Inc. (MM) (NASDAQ:ATMI)
Historical Stock Chart
From Jul 2023 to Jul 2024